Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis.

Jens Benn Sørensen, Heine H. Hansen, M Hansen, +1

Journal of Clinical Oncology

Neuro-oncologyBrain MetastasesGliomaMedicineBrain Metastasis +13

Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.

Ulrik Lassen, M Hansen, P Dombernowsky, +2

Journal of Clinical Oncology

Advanced epithelial ovarian cancer: 1993 consensus statements

Darlene Allen, J. Baak, D Belpomme, +27

Annals of Oncology

Gynecological SurgeryMedicineGynecologyConsensus StatementsOncology +2

Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants.

Heine H. Hansen, M Hansen, P Dombernowsky, +1

Journal of Clinical Oncology

Clinical DeterminantsMedicineLong-term Disease-free SurvivalPathologySmall-cell Carcinoma +10

Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer.

J Pedersen-Bjergaard, Torben Sigsgaard, Dorte Nielsen, +7

Journal of Clinical Oncology

Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancer.

Dorte Nielsen, Jørgen Bjerggaard Jensen, P Dombernowsky, +5

Journal of Clinical Oncology

Heart FailureBreast OncologyPathologyPharmacotherapyCardiovascular Toxicity +15

Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-up

Kell Østerlind, Heine H. Hansen, HH Hansen, +3

British Journal of Cancer

Radiation MedicineOncologyChemotherapy Versus ChemotherapyRadiation TherapyBronchial Neoplasm +5

Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small cell carcinoma of the lung

J Pedersen-Bjergaard, M Hansen, Preben Philip, +2

Blood

Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.

E Bork, M Hansen, P Dombernowsky, +3

Journal of Clinical Oncology

Cancer ManagementPharmacotherapyMetronomic ChemotherapyOncologyMarrow Metastases +16

High-dose platinum consisting of combined carboplatin and cisplatin in previously untreated ovarian cancer patients with residual disease.

Birthe Lund, M Hansen, Ole Hansen, +1

Journal of Clinical Oncology

GynecologyPharmacotherapyMetronomic ChemotherapyResidual DiseaseOvarian Cancer +14